0001437749-20-023178.txt : 20201109 0001437749-20-023178.hdr.sgml : 20201109 20201109135655 ACCESSION NUMBER: 0001437749-20-023178 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 37 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201109 DATE AS OF CHANGE: 20201109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCULUS VISIONTECH INC. CENTRAL INDEX KEY: 0001107280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061576391 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-29651 FILM NUMBER: 201297040 BUSINESS ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 BUSINESS PHONE: 6046851017 MAIL ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 FORMER COMPANY: FORMER CONFORMED NAME: OCULUS VISION TECH INC. DATE OF NAME CHANGE: 20120201 FORMER COMPANY: FORMER CONFORMED NAME: USA VIDEO INTERACTIVE CORP DATE OF NAME CHANGE: 20000217 10-Q 1 ovtz20200930_10q.htm FORM 10-Q ovtz20200930_10q.htm
 

 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

  

For the quarterly period ended September 30, 2020

  

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

  

For the transition period from _____ to _____

  

Commission File Number: 0-29651

  

OCULUS VISIONTECH INC.

(Exact name of registrant as specified in its charter)

  

Wyoming

06-1576391

(State or Other Jurisdiction of

(I.R.S. Employer

Incorporation or Organization)

Identification No.)

  

Suite 507 - 837 West Hastings Street, Vancouver, BC, Canada, V6C 3N6

(Address of principal executive offices) (Zip code)

(604) 685-1017

(Registrant’s telephone number, including area code)

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

  

Yes   ☑      No   ☐

  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

  

Yes    ☑      No ☐

  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” ‘‘accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

  

Large accelerated filer

Accelerated filer

Non-accelerated filer     

Smaller reporting company   

  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☑

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

  

Yes    ☐      No ☑

  

As of November 9, 2020, there were 86,522,569 shares of the registrant’s common stock outstanding.

  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common

  

  

Common stock - no par value

OVTZ

Over The Counter Bulletin Board

Preferred stock - no par value

N/A

N/A

Common stock - no par value

OVT

TSX Venture Exchange

Common stock - no par value

USF1

Frankfurt Stock Exchange

 

 
 
 

TABLE OF CONTENTS

  

  

  

PART I – FINANCIAL INFORMATION

  

  

  

  

  

Item 1.

  

Financial Statements

3

  

(A)

Condensed Interim Consolidated Balance Sheets

3

  

(B)

Condensed Interim Consolidated Statements of Operations

4

  

(C)

Condensed Interim Consolidated Statements Of Stockholders’ Equity

5

  

(D)

Condensed Interim Consolidated Statements of Cash Flows

6

  

(E)

Notes to Condensed Interim Consolidated Financial Statements

7

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

9

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

13

Item 4.

  

Controls and Procedures

13

  

  

  

  

  

  

PART II – OTHER INFORMATION

  

  

  

  

  

Item 1.

  

Legal Proceedings

14

Item 1A.     

  

Risk Factors

14

Item 2.

  

Unregistered Sales of Equity Securities and Use of Proceeds

14

Item 3.

  

Defaults Upon Senior Securities

14

Item 4.

  

Mine Safety Disclosure

14

Item 5.

  

Other Information

14

Item 6.

  

Exhibits

14

    

 

 

PART I - FINANCIAL INFORMATION

  

Item 1. Financial Statements.

  

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars)

 


 

   

September 30,

   

December 31,

 
   

2020

   

2019

 
   

(Unaudited)

   

(Audited)

 

ASSETS

               
                 

Current Assets:

               

Cash and cash equivalents

  $ 695,835     $ 382,452  

Prepaid expenses and other current assets

    4,686       1,267  

Total current assets

    700,521       383,719  
                 

Intangible assets (Note 3)

    1,966,939       -  

Total Assets

  $ 2,667,460     $ 383,719  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               
                 

Current Liabilities:

               

Accounts payable and accrued expenses

  $ 50,611     $ 5,431  

Accounts payable and accrued expenses - related parties

    135,484       129,985  

Total current liabilities

    186,095       135,416  
                 

Commitments and Contingencies

    -       -  
                 

Stockholders' Equity:

               

Preferred stock - no par value; authorized 250,000,000 shares, none issued

               

Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 86,522,569

    43,908,562       41,634,999  

Commitment to issue shares (Note 3)

    414,128       -  

Accumulated deficit

    (41,841,325

)

    (41,386,696

)

Stockholders' equity

    2,481,365       248,303  

Total Liabilities and Stockholders' Equity

  $ 2,667,460     $ 383,719  

 

SEE ACCOMPANYING NOTES

  

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Stated in US Dollars)

(Unaudited)

 


  

   

For the three-month ended

September 30,

   

For the nine-month ended

September 30,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Revenue

  $ -     $ -     $ -     $ -  
                                 

Expenses:

                               

Research and development

    93,270       -       130,180       -  

Selling, general and administrative

    83,605       43,098       204,447       165,264  

Stock-based compensation (Note 5)

    120,098       -       120,098       -  
                                 

Total expenses

    296,973       43,098       454,725       165,264  

Loss from operations

    (296,973 )     (43,098 )     (454,725 )     (165,264 )
                                 

Other income (expense)

                               

Interest income (expense)

    -       281       96       281  
                                 

Net loss

  $ (296,973 )   $ (42,817 )   $ (454,629 )   $ (164,983 )
                                 

Net loss per share - basic and diluted

  $ (0.00 )   $ (0.00 )   $ (0.01 )   $ (0.00 )
                                 

Weighted average number of common shares outstanding – basic and diluted

    86,522,569       67,022,568       78,165,426       53,665,425  

  

SEE ACCOMPANYING NOTES

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Stated in US Dollars)

(Unaudited)

 


 

   

Common Stock and

                         
   

Additional Paid in

                         
   

Capital

                         
                   

Commitment to

   

Accumulated

   

Stockholders'

 
   

Shares

    Amount    

Issue Shares

   

Deficit

   

Equity

 
                                         
                                         

Balance at December 31, 2018

    45,572,568     $ 40,458,297     $ -     $ (41,193,831 )   $ (735,534 )
                                         

Sale of common stock, net of $32,416 of issuance cost

    21,450,000       1,176,702       -       -       1,176,702  

Net loss

    -       -       -       (164,983 )     (164,983 )
                                         

Balance at September 30, 2019

    67,022,568     $ 41,634,999     $ -     $ (41,358,814 )   $ 276,185  
                                         
                                         

Balance at December 31, 2019

    67,022,568     $ 41,634,999     $ -     $ (41,386,696 )   $ 248,303  
                                         

Sale of common stock

    7,000,001       773,038       -       -       773,038  

Shares issued for asset acquisition (Note 3)

    12,500,000       1,380,427       -       -       1,380,427  

Contingent consideration

    -       -       414,128       -       414,128  

Share-based compensation

    -       120,098       -       -       120,098  

Net loss

    -       -       -       (454,629 )     (454,629 )
                                         
                                         

Balance at September 30, 2020

    86,522,569     $ 43,908,562     $ 414,128     $ (41,841,325 )   $ 2,481,365  

 

SEE ACCOMPANYING NOTES

  

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in US Dollars)

 


 

Six months ended September 30,

 

2020

   

2019

 

(Unaudited)

 

Cash flows from operating activities:

               

Net loss

  $ (454,629

)

  $ (164,983

)

Add back non-cash share-based compensation

    120,098       -  

Adjustments to reconcile net loss to net cash used in operating activities:

               

Changes in operating assets and liabilities:

               

Decrease (increase) in prepaid expenses and other current assets

    (3,419

)

    461  

Increase (decrease) in accounts payable and accrued expenses

    (241,373

)

    (48,706

)

Increase (decrease) in accounts payable and accrued expenses due to related parties

    5,499       (556,154

)

                 

Net cash used in operating activities

    (573,824

)

    (769,382

)

                 

Cash flows from investing activities

               

Cash acquired on asset acquisition

    114,169       -  

Net cash from investing activities

    114,169       -  
                 

Cash flows from financing activities

               

Proceeds from the sale of common stock

    773,038       1,176,702  

Net cash from financing activities

    773,038       1,176,702  
                 

Net increase in cash and cash equivalents

    313,383       407,320  
                 

Cash and cash equivalents at beginning of period

    382,452       5,572  

Cash and cash equivalents at end of period

  $ 695,835     $ 412,892  
                 
                 

Supplemental disclosures of cash flow information:

               
                 

Cash paid during the period for interest

  $ -     $ -  

Cash paid during the period for income taxes

  $ -     $ -  
                 
                 
                 

Non-Cash Financing and Investing Activities

               
                 

Common stock issued on acquisition

  $ 1,380,427          

Intangible acquired on acquisition

    (1,966,939 )        

Warrants issued on acquisition

    414,128          

Account payable acquired on acquisition

    172,384          
    $ -          

 

SEE ACCOMPANYING NOTES

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

  

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2020 and 2019 

(Stated in US Dollars)

(Unaudited)

  

 

1.

BASIS OF PRESENTATION

  

These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended December 31, 2019. These unaudited condensed interim consolidated financial statements do not include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended December 31, 2019, except when disclosed below.

  

The accompanying consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, USVO Inc. (dissolved December 31, 2019) and OCL Technologies Corp. (from the date of acquisition, Note 3). All intercompany balances and transactions have been eliminated upon consolidation.   In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are not necessarily indicative of the results that may be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2019.

  

 

2.

GOING CONCERN

  

The accompanying unaudited condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As shown in the financial statements, the Company has incurred a loss of $454,629 for the nine month period ended September 30, 2020 and, in addition the Company incurred losses of $192,865 and $183,279 for the years ended December 31, 2019 and 2018, respectively. As of September 30, 2020, the Company had an accumulated deficit of $41,841,325 and a working capital of $514,426. These conditions raise doubt about the Company’s ability to continue as a going concern.  The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.

  

 

3.

ACQUISITION OF OCL TECHNOLOGIES CORP. 

 

During the period ended September 30, 2020, the Company acquired a 100% interest in OCL Technologies Corp. (“OCL”) by issuing 12,500,000 shares with a fair value of $1,380,427 and contingent consideration consisting of 12,500,000 non transferable warrants with a fair value of $414,128. The transaction does not meet the definition of a business as defined in ASC 805-10. As a result, the acquisition of OCL has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, OCL became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:

 


 

Purchase Price

       
         

Issuance of 12,500,000 shares

  $ 1,380,427  

Contingent consideration - warrants

    414,128  

Transaction costs

    54,532  
         

Total Purchase Price

  $ 1,849,087  

 

 

Contingent consideration consists of 12,500,000 non-transferable warrants that are exercisable into 12,500,000 common shares if certain criteria are met at an exercise price of $0.001 for a period of five years from the date of issuance expiry June 4, 2025. No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per OCL’s 5 year proformas, or 2) listing on a major US exchange, or 3) change of control. The Company has estimated the fair value of the contingent consideration to be $414,128.

 


 

Purchase Price Allocation

       
         

Cash

  $ 114,169  

Accounts payable and due from related party

    (232,021 )

Intangible asset

    1,966,939  
         

Total Purchase Price

  $ 1,849,087  

 

 

4.

COMMON STOCK 

 

On June 19, 2019, the Company issued 7,500,000 shares to a consultant and directors at $0.075 CND per share.

 

On June 19, 2019, the Company issued 13,950,000 shares to investors at $0.075 CND per share.

 

On June 5, 2020, the Company issued 12,500,000 shares at a value of $0.15 CND per share pursuant to the acquisition of OCL Technologies Corp.

 

On June 5, 2020, the Company issued 7,000,001 shares to investors, including 1,766,667 common shares to a consultant and directors at $0.15 CND per share.

 

 

5.

STOCK OPTIONS  

 

On September 30, 2019, the Company adopted Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options.

 

During the period ended September 30, 2020, the Company granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of $0.35CND and an expiry date of July 21, 2023. The options have a fair value of $909,900CND, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.27%; (iv) Dividend rate of Nil; and (v) market stock price of $0.35. The options vest 20% every 6 months starting January 21, 2020. During the period ended September 30, 2020, the Company recorded $160,990CND ($120,098US) of stock-based compensation relating to the vesting period.

 

 

6.

COVID-19  

 

In early 2020, a coronavirus that causes COVID-19 emerged globally, which is currently affecting the global economies and has a resulting effect on the Company. Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.

  

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

  

FORWARD-LOOKING STATEMENTS AND SUPPLEMENTARY DATA

  

The following discussion should be read in conjunction with our condensed interim financial statements and other financial information appearing elsewhere in this quarterly report. In addition to historical information, the following discussion and other parts of this quarterly report contain forward-looking statements under applicable securities laws. You can identify these statements by forward-looking words such as “plan”, “may”, “will”, “expect”, “intend”, “anticipate”, believe”, “estimate” and “continue” or similar words. Forward-looking statements are statements that are not historical facts, and include, but are not limited to, statements regarding the Company’s digital watermarking technology and Cloud Document Protection System (C-DPS),the Company’s expenses related to the Alpha and Beta testing of its digital water marketing technology and Cloud Document Protection System, the anticipated development and commercialization date of its Cloud Document Protection System, the future sources and availability of additional funding, and the effect of funding arrangements on projects and products. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Accordingly, we do not undertake any obligation to update any forward-looking statements for any reason, even if new information becomes available or other events occur in the future, except as required by law.

  

The forward-looking statements included herein are based on current expectations that involve a number of risks and uncertainties set forth under “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and other periodic reports filed with the United States Securities and Exchange Commission (“SEC”). Accordingly, to the extent that this quarterly report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of the Company, please be advised that the Company’s actual financial condition, operating results and business performance may differ materially from that projected or estimated by the Company in forward-looking statements.

  

OVERVIEW OF THE COMPANY

  

We have recognized that Internet-based, digital document security/protection products are a business opportunity for the Company that allow us to apply our proprietary real-time digital video watermarking technology, which was developed for studios and networks in the entertainment industry, to the digital document security/protection sector. Our Cloud-DPS technology introduces the Company to the online, digital document security/protection industry and possible vertical markets that exist in the sector, including the ability to confirm the authenticity of online documents and photographs distributed through traditional wireline networks or over wireless smart devices.

  

 

Our Cloud-DPS secures and protects digital documents (including text documents, photos, blueprints, etc.) from any modification, and/or attempted forgery. It works by imperceptibly watermarking documents, using real-time image processing and watermarking algorithms, embedded into a secured/protected copy of a document. This protected copy is designed to resist any attempts to alter or forge the document by forensically tracking and deterring any attempts to tamper with the document. The watermarking algorithms are able to ascertain whether a document is protected by our DPS technology and if any attempts to modify or tamper with the document occurred. Any such modifications will be flagged, time stamped, and can be spatially highlighted in the document where any tampering occurred. This authentication and verification process ensures the integrity of the original document. 

 

We currently have no customers for our products and services. We are taking steps to monetarize our Cloud-DPS technology. These steps include actively seeking licensing initiatives. Our DPS architecture is designed as a web service, which allows for an easy customization to individual customer needs. The main customization effort is reduced by our creation of well synchronized interfaces to a potential customer's infrastructure. This feature will allow us to offer "white label" licensing of our DPS technology. 

 

  

BUSINESS OBJECTIVES:

  

We have established the following near-term business objectives:

  

1.

Patent and license new technology developed within the corporate research and development program;

  

2.

Demonstrate proof of concept on selected commercial projects with C-DPS – Cloud Document Protection System and gain industry recognition for the architectural and business differentiators of company’s C-DPS product’s authentication and tamper-proof functionality.

  

ACQUISITION OF OCL TECHNOLOGIES CORP.

 

On June 5, 2020, the Company completed the acquisition of 100% of the shares of OCL Technologies Corp. www.ocltechnologies.com (hereafter “OCL”), a Delaware Corporation, with its head office located in the technology hub of San Diego, California. OCL is specifically focused on providing enterprise organizations and individuals with highly-secure data privacy tools that provide sustained and continuous global regulatory compliance of data subject rights, while independently protecting all parties. With the burgeoning growth of privacy regulation worldwide coupled with strict regulatory oversight, companies are dedicating significant resources to achieve and maintain compliance. In the past two years alone, initiatives such as the EU GDPR (General Data Protection Regulation effective May 25, 2018) as well as the CCPA (California Consumer Privacy Act passed June 28, 2018 and effective January 1, 2020) have mandated privacy rights and data protection for entities and individuals contemplated within their legislative frameworks. In addition to these, there are additional data privacy legislative initiatives on-going in Asia and both North and South America which will require data protection solutions. The OCL cloud-native zero-trust data privacy API tool will provide secure, continuous regulatory compliance of a data subject’s ‘Right-to-be-Forgotten’ and ‘Right-of-Erase’ requests through a systematic consent/collect/store/verification process, protecting both the data subject and data controller. This initial entry into the market od data compliance will pave the way for more offerings as the OCL product platform matures. The Company believes that the acquisition of OCL is a tremendous fit within its core objective of developing robust cutting edge technologies that address focused customer data protection requirements on a global scale.

 

Contingent consideration consists of 12,500,000 non-transferable warrants that are exercisable into 12,500,000 common shares if certain criteria are met at an exercise price of $0.001 for a period of five years from the date of issuance expiry June 4, 2025. No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per OCL’s 5 year proformas, or 2) listing on a major US exchange, or 3) change of control. The Company has estimated the fair value of the contingent consideration to be $414,128.

 

CRITICAL ACCOUNTING POLICIES (AND ESTIMATES)

  

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, we evaluate these estimates, including those related to customer programs and incentives, bad debts, inventories, investments, intangible assets, income taxes, warranty obligations, impairment or disposal of long-lived assets, contingencies and litigation.  We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.

  

 

We have identified the policies below as critical to our business operations and to the understanding of our financial results. The impact and any associated risks related to these policies on our business operations is discussed throughout management’s discussion and analysis of financial condition and results of operations where such policies affect our reported and expected financial results:  

 

 

Revenue recognition;

 

Impairment or disposal of long-lived assets;

 

Deferred taxes;

 

Accounting for stock-based compensation; and

 

Commitments and contingencies.

  

Revenue Recognition.  In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASC 606"). This guidance outlines a single, comprehensive model for accounting for revenue from contracts with customers to depict the transfer of control over a product to a customer. The guidance's core principle is that the Company will recognize revenue when it transfers control over promised goods or services to customers in an amount that reflects consideration to which the Company expects to be entitled in exchange for those goods or services.

 

Under ASC 606, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to a customer. The Company's contracts with customers typically contain a single performance obligation. A contract's transaction price is allocated to its distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. If there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on their relative standalone selling prices. Sales are recorded net of sales returns, discounts and allowances.

 

Impairment or Disposal of Long-Lived Assets.  Long-lived assets are reviewed in accordance with ASC Topic 360-10-05.  Impairment or disposal of long-lived assets losses are recognized in the period the impairment or disposal occurs.  

  

Deferred Taxes.  We record a valuation allowance to reduce deferred tax assets when it is more likely than not that some portion of the amount may not be realized.  

  

Accounting for Stock-Based Compensation.  Under ASC Topic 718, Stock Compensation (formerly referred to as SFAS No. 123(R)), the Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of the Company’s common stock, pre-vesting forfeiture rate and an option’s expected life. The financial statements include amounts that are based on the Company’s best estimates and judgments.

  

Commitments and Contingencies.  We account for commitments and contingencies in accordance with ASC Topic 450 Contingencies (formerly referred to as financial accounting standards board Statement No. 5, Accounting for Contingencies). We record a liability for commitments and contingencies when the amount is both probable and reasonably estimable.

  

RESULTS OF OPERATIONS

  

For the Nine Months Ended September 30, 2020

 

Sales

  

Sales for the nine-month period ended September 30, 2020 and 2019 were $-0-

  

Cost of Sales

  

The cost of sales for the nine months ended September 30, 2020 and 2019 were $-0-.

  

 

Selling, General and Administrative Expenses

  

Selling, general and administrative expenses, consisting of product marketing expenses, consulting fees, office, professional fees and other expenses to execute our business plan and for our day-to-day operations, increased in the nine months ending September 30, 2020.  We continue to develop and market C-DPS – Cloud Document Protection System and the “Right-to-be-Forgotten” and “Right-to-Erase” platform. Administrative expenses have decreased/increased moderately as a result of insignificant fluctuations in general costs.

 

Selling, general and administrative expenses for the nine months ended September 30, 2020 increased by $39,183 to $204,447 from $165,264 for the nine months ended September 30, 2019. This included professional expenses for the nine months ended September 30, 2020 which increased to $64,595 from $34,660 for the comparable period in 2019. We incurred increased costs in 2020 due to post acquisition legal and accounting costs.

 

Research and development for the nine months ended September 30, 2020 increased to $130,180 from $18,350 for the comparable period in 2019. This was a result of the Company’s acquisition of OCL and the research that they conduct.

 

Currency exchange expense for the nine months ended September 30, 2020, increased to $24,772 from $33 for the comparable period in 2019. We incurred increased costs in 2020 due to the change in the Canadian dollar and the United States dollar.

  

We have arranged for additional staff and consultants to engage in marketing activities in an effort to identify and assess appropriate market segments, develop business arrangements with prospective partners, create awareness of new products and services, and communicate to the industry and potential customers. Other components of selling, general and administrative expenses did not change significantly.

  

Research and Development

  

Research and development costs for the three months ended September 30, 2020, increased to $93,270 from $-0- for the comparable period in 2019. We incurred increased costs in 2020 due to management’s decision to develop C-DPS – Cloud Document Protection System as well as the development of our subsidiary’s zero trust data privacy platform. (“Right-to-be-Forgotten” and “Right-to-Erase”).

  

Net Losses

  

To date, we have not achieved profitability and expect to incur substantial losses for the foreseeable future. Our net loss for the three months ended September 30, 2020 was $296,973 compared with a net loss of $164,983 for 2019.

  

Liquidity and Capital Resources

  

At September 30, 2020, our cash position was $695,835, compared $382,452 at December 31, 2019. We had a working capital of $514,426 and an accumulated deficit of $41,841,325 at September 30, 2020.

 

We have historically satisfied our capital needs primarily by issuing equity securities to our officers, directors, employees and a small group of investors, and from short-term bridge loans from members of management. During the period ended September 30, 2020, the company issued 7,000,001 shares for proceeds of $773,038 and received $114,169 in cash on the acquisition of assets.

  

Off-Balance Sheet Arrangements

  

We do not maintain any off-balance sheet transactions, arrangements, or obligations that are reasonably likely to have a material effect on our financial condition, results of operations, liquidity, or capital resources.

  

RELATED PARTY TRANSACTIONS

  

The Company for the nine months ended September 30, 2020 and 2019 reimbursed a related party $6,071 and $6,015, respectively. The Company incurred $106,000 from a related party for research and development for the nine months ended September 30, 2020 and $0 for 2019. At September 30, 2019, the Company owed companies controlled by related parties $129,766 (2019 - $129,985).

 

  

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

  

Oculus is a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and is not required to provide information required under this Item.

  

Item 4.

Controls and Procedures.

  

We maintain “disclosure controls and procedures”, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

  

As of September 30, 2020, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

  

Changes in Internal Control over Financial Reporting

  

There were no changes in the our internal control over financial reporting for the nine month period ended September 30, 2020, identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15, that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

   

 

PART II - OTHER INFORMATION

  

Item 1.

Legal Proceedings.

  

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

  

Item 1A.

Risk Factors.

  

Oculus is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide information required under this Item. A description of the risks associated with our business, financial condition, and results of operations is set forth in Part I, Item 1A, of our Annual Report on Form 10 -K for the fiscal year ended December 31, 2019 filed with the SEC on September 30, 2020. Those factors continue to be meaningful for your evaluation of Oculus and we urge you to review and consider the risk factors presented in such Form 10-K.

  

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

  

None.

  

Item 3.

Defaults Upon Senior Securities.

  

None.

  

Item 4.

Mine Safety Disclosures.

  

Not applicable.

  

Item 5.

Other Information.

 

None.

 

Item 6.

Exhibits.

  

The information required by this Item is set forth on the exhibit index which follows the signature page of this report.

  

Exhibit

No.

Description

 

 

EX-31.1

Certification of CEO

 

 

EX-31.2

Certification of CFO

 

 

EX-32.1

SOX Certification of CEO

 

 

EX-32.2

SOC Certification of CFO

 

101.INS

XBRL Instance Document

 

 

101.SCH

XBRL Taxonomy Extension Schema Document

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

 

 

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

SIGNATURES

  

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  

  

OCULUS VISIONTECH INC.

  

  

  

November 9, 2020

By:

/s/ Rowland Perkins

  

  

  

Rowland Perkins

  

  

President and Chief Executive Officer

  

  

(principal executive officer)

  

  

  

 

 

 

November 9, 2020

By:

/s/ Anton J. Drescher

  

  

  

Anton J. Drescher

  

  

Chief Financial Officer

  

  

(principal financial and accounting officer)

  

15
EX-31.1 2 ex_212595.htm EXHIBIT 31.1

EXHIBIT 31.1

 

CERTIFICATION

 

I, Rowland Perkins, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 9, 2020

By:

/s/ Rowland Perkins

 

 

 

Rowland Perkins

 

 

 

Chief Executive Officer

(Principal Executive Officer)

 

 

 
EX-31.2 3 ex_212596.htm EXHIBIT 31.2

 EXHIBIT 31.2

 

CERTIFICATIONS

 

I, Anton J. Drescher, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 9, 2020

By:

/s/ Anton J. Drescher

 

 

 

Anton J. Drescher

 

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 
EX-32.1 4 ex_212597.htm EXHIBIT 32.1

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Oculus VisionTech Inc. (the “Company”), for the period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rowland Perkins, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

 

Date : November 9, 2020

By:

/s/ Rowland Perkins

 

 

 

Rowland Perkins

 

 

 

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 
EX-32.2 5 ex_212598.htm EXHIBIT 32.2

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Oculus VisionTech Inc. (the “Company”), for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Anton J. Drescher , Chief Financial Officer for the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

 

Date: November 9, 2020

By:

/s/ Anton J. Drescher

 

 

 

Anton J. Drescher

 

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 

 
EX-101.INS 6 ovtz-20200930.xml XBRL INSTANCE DOCUMENT false --12-31 Q3 2020 2020-09-30 10-Q 0001107280 86522569 Yes true true Non-accelerated Filer Yes OCULUS VISIONTECH INC. false true Common Stock ovtz 12500000 909900 0.1 -514426 50611 5431 120098 120098 32416 414128 414128 160990 120098 120098 120098 2667460 383719 700521 383719 54532 12500000 1 1849087 1380427 1380427 414128 114169 232021 1966939 1849087 114169 695835 382452 382452 5572 695835 412892 313383 407320 0.001 12500000 12500000 0 0 500000000 500000000 86522569 86522569 86522569 86522569 43908562 41634999 296973 43098 454725 165264 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">5</div></div><div style="display: inline; font-weight: bold;">. </div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">STOCK OPTIONS&nbsp;&nbsp;</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2019, </div>the Company adopted Rolling Stock Option Plan. Up to <div style="display: inline; font-style: italic; font: inherit;">10%</div> of the Company's issued and outstanding common shares <div style="display: inline; font-style: italic; font: inherit;"> may </div>be reserved for granting of stock options.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">During the period ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>the Company granted <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">3,600,000</div></div> stock options to consultants, directors and officers exercisable into <div style="display: inline; font-style: italic; font: inherit;">3,600,000</div> shares at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$0.35CND</div> and an expiry date of <div style="display: inline; font-style: italic; font: inherit;"> July 21, 2023. </div>The options have a fair value of <div style="display: inline; font-style: italic; font: inherit;">$909,900CND,</div> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <div style="display: inline; font-style: italic; font: inherit;">125%;</div> (ii) Term of <div style="display: inline; font-style: italic; font: inherit;">3</div> years; (iii) Discount rate of <div style="display: inline; font-style: italic; font: inherit;">0.27%;</div> (iv) Dividend rate of <div style="display: inline; font-style: italic; font: inherit;">Nil;</div> and (v) market stock price of <div style="display: inline; font-style: italic; font: inherit;">$0.35.</div> The options vest <div style="display: inline; font-style: italic; font: inherit;">20%</div> every <div style="display: inline; font-style: italic; font: inherit;">6</div> months starting <div style="display: inline; font-style: italic; font: inherit;"> January 21, 2020. </div>During the period ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>the Company recorded <div style="display: inline; font-style: italic; font: inherit;">$160,990CND</div> (<div style="display: inline; font-style: italic; font: inherit;">$120,098US</div>) of stock-based compensation relating to the vesting period.</div></div> 135484 129985 0 0 -0.01 0 -241373 -48706 5499 -556154 3419 -461 1966939 281 96 281 2667460 383719 186095 135416 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">3.</div> </div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">ACQUISITION OF OCL TECHNOLOGIES CORP.&nbsp;</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">During the period ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>the Company acquired a <div style="display: inline; font-style: italic; font: inherit;">100%</div> interest in OCL Technologies Corp. (&#x201c;OCL&#x201d;) by issuing <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> shares with a fair value of <div style="display: inline; font-style: italic; font: inherit;">$1,380,427</div> and contingent consideration consisting of <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> non transferable warrants with a fair value of <div style="display: inline; font-style: italic; font: inherit;">$414,128.</div> The transaction does <div style="display: inline; font-style: italic; font: inherit;">not</div> meet the definition of a business as defined in ASC <div style="display: inline; font-style: italic; font: inherit;">805</div>-<div style="display: inline; font-style: italic; font: inherit;">10.</div> As a result, the acquisition of OCL has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, OCL became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <hr style="text-align: left;height: 3px; color: #000000; background-color: #000000; width: 90%; border: none; margin: 0pt auto 0pt 0pt;" /> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Issuance of 12,500,000 shares</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,380,427</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Contingent consideration - warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">414,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Transaction costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">54,532</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Contingent consideration consists of <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> non-transferable warrants that are exercisable into <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> common shares if certain criteria are met at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$0.001</div> for a period of <div style="display: inline; font-style: italic; font: inherit;">five</div> years from the date of issuance expiry <div style="display: inline; font-style: italic; font: inherit;"> June 4, 2025. </div><div style="display: inline; font-style: italic; font: inherit;">No</div> share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being <div style="display: inline; font-style: italic; font: inherit;">1</div>) revenue sales projections per OCL's <div style="display: inline; font-style: italic; font: inherit;">5</div> year proformas, or <div style="display: inline; font-style: italic; font: inherit;">2</div>) listing on a major US exchange, or <div style="display: inline; font-style: italic; font: inherit;">3</div>) change of control. The Company has estimated the fair value of the contingent consideration to be <div style="display: inline; font-style: italic; font: inherit;">$414,128.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <hr style="text-align: left;height: 3px; color: #000000; background-color: #000000; width: 90%; border: none; margin: 0pt auto 0pt 0pt;" /> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price Allocation</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">114,169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable and due from related party</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(232,021</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Intangible asset</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,966,939</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table> </div></div> 773038 1176702 114169 -573824 -769382 -454629 -192865 -183279 -164983 -296973 -42817 -164983 -454629 1966939 414128 172384 -296973 -43098 -454725 -165264 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">1.</div> </div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">BASIS OF PRESENTATION </div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (&#x201c;Oculus&#x201d; or the &#x201c;Company&#x201d;) most recently completed fiscal year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019. </div>These unaudited condensed interim consolidated financial statements do <div style="display: inline; font-style: italic; font: inherit;">not</div> include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019, </div>except when disclosed below.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The accompanying consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, USVO Inc. (dissolved <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019) </div>and OCL Technologies Corp. (from the date of acquisition, Note <div style="display: inline; font-style: italic; font: inherit;">3</div>). All intercompany balances and transactions have been eliminated upon consolidation. &nbsp; In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company's annual report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the fiscal year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019.</div></div></div> 0 0 250000000 250000000 0 0 0 0 4686 1267 773038 1176702 93270 130180 -41841325 -41386696 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Issuance of 12,500,000 shares</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,380,427</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Contingent consideration - warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">414,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Transaction costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">54,532</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 83%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price Allocation</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Cash</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">114,169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable and due from related party</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(232,021</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Intangible asset</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,966,939</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table></div> 83605 43098 204447 165264 120098 0.0027 0.35 0 1.25 3600000 0.35 3600000 0.2 P3Y 45572568 67022568 67022568 86522569 0.075 0.075 0.15 0.15 0.15 12500000 7500000 13950000 12500000 7000001 1766667 21450000 7000001 1380427 1380427 1176702 1176702 773038 773038 2481365 248303 40458297 -41193831 -735534 41634999 -41358814 276185 41634999 -41386696 43908562 414128 -41841325 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">4</div></div><div style="display: inline; font-weight: bold;">. </div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">COMMON STOCK&nbsp;</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> June 19, 2019, </div>the Company issued <div style="display: inline; font-style: italic; font: inherit;">7,500,000</div> shares to a consultant and directors at <div style="display: inline; font-style: italic; font: inherit;">$0.075</div> CND per share.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> June 19, 2019, </div>the Company issued <div style="display: inline; font-style: italic; font: inherit;">13,950,000</div> shares to investors at <div style="display: inline; font-style: italic; font: inherit;">$0.075</div> CND per share.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> June 5, 2020, </div>the Company issued <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> shares at a value of <div style="display: inline; font-style: italic; font: inherit;">$0.15</div> CND per share pursuant to the acquisition of OCL Technologies Corp.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> June 5, 2020, </div>the Company issued <div style="display: inline; font-style: italic; font: inherit;">7,000,001</div> shares to investors, including <div style="display: inline; font-style: italic; font: inherit;">1,766,667</div> common shares to a consultant and directors at <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">$0.15</div></div> CND per share.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">2.</div> </div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">GOING CONCERN </div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The accompanying unaudited condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern. &nbsp;As shown in the financial statements, the Company has incurred a loss of <div style="display: inline; font-style: italic; font: inherit;">$454,629</div> for the <div style="display: inline; font-style: italic; font: inherit;">nine</div> month period ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020 </div>and, in addition the Company incurred losses of <div style="display: inline; font-style: italic; font: inherit;">$192,865</div> and <div style="display: inline; font-style: italic; font: inherit;">$183,279</div> for the years ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font: inherit;">2018,</div> respectively. As of <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>the Company had an accumulated deficit of <div style="display: inline; font-style: italic; font: inherit;">$41,841,325</div> and a working capital of <div style="display: inline; font-style: italic; font: inherit;">$514,426.</div> These conditions raise doubt about the Company's ability to continue as a going concern. &nbsp;The Company's ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do. &nbsp;To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company's management. &nbsp;The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company's management will continue to be available to the Company when needed. &nbsp;The financial statements do <div style="display: inline; font-style: italic; font: inherit;">not</div> include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">6</div></div><div style="display: inline; font-weight: bold;">. </div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div></div><div style="display: inline; font-weight: bold;">&nbsp;&nbsp;</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In early <div style="display: inline; font-style: italic; font: inherit;">2020,</div> a coronavirus that causes COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> emerged globally, which is currently affecting the global economies and has a resulting effect on the Company. Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</div></div> 414128 414128 414128 P5Y 86522569 67022568 78165426 53665425 xbrli:shares xbrli:pure iso4217:CAD xbrli:shares iso4217:USD iso4217:CAD iso4217:USD xbrli:shares 0001107280 2018-01-01 2018-12-31 0001107280 2019-01-01 2019-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2019-01-01 2019-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001107280 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001107280 2019-01-01 2019-12-31 0001107280 ovtz:EmployeeAndDirectorsMember 2019-06-19 2019-06-19 0001107280 ovtz:InvestorsMember 2019-06-19 2019-06-19 0001107280 2019-07-01 2019-09-30 0001107280 2020-01-01 2020-09-30 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2020-01-01 2020-09-30 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-09-30 0001107280 ovtz:OCLTechnologiesCorpMember 2020-01-01 2020-09-30 0001107280 ovtz:OCLTechnologiesCorpMember ovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember 2020-01-01 2020-09-30 0001107280 ovtz:RollingStockOptionPlanMember 2020-01-01 2020-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2020-01-01 2020-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001107280 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001107280 ovtz:RollingStockOptionPlanMember 2020-01-01 2020-09-30 0001107280 ovtz:Covid19Member 2020-01-01 2020-09-30 0001107280 ovtz:EmployeeAndDirectorsMember 2020-06-05 2020-06-05 0001107280 ovtz:InvestorsMember 2020-06-05 2020-06-05 0001107280 ovtz:OCLTechnologiesCorpMember 2020-06-05 2020-06-05 0001107280 2020-07-01 2020-09-30 0001107280 2018-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2018-12-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0001107280 us-gaap:RetainedEarningsMember 2018-12-31 0001107280 ovtz:EmployeeAndDirectorsMember 2019-06-19 0001107280 ovtz:InvestorsMember 2019-06-19 0001107280 2019-09-30 0001107280 ovtz:RollingStockOptionPlanMember 2019-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2019-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-09-30 0001107280 us-gaap:RetainedEarningsMember 2019-09-30 0001107280 2019-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2019-12-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0001107280 us-gaap:RetainedEarningsMember 2019-12-31 0001107280 ovtz:EmployeeAndDirectorsMember 2020-06-05 0001107280 ovtz:InvestorsMember 2020-06-05 0001107280 ovtz:OCLTechnologiesCorpMember 2020-06-05 0001107280 2020-09-30 0001107280 ovtz:OCLTechnologiesCorpMember 2020-09-30 0001107280 ovtz:OCLTechnologiesCorpMember ovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember 2020-09-30 0001107280 ovtz:RollingStockOptionPlanMember 2020-09-30 0001107280 ovtz:CommitmentToIssueSharesMember 2020-09-30 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-09-30 0001107280 us-gaap:RetainedEarningsMember 2020-09-30 0001107280 ovtz:RollingStockOptionPlanMember 2020-09-30 0001107280 2020-11-09 EX-101.SCH 7 ovtz-20200930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 1 - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 2 - Going Concern link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 4 - Common Stock link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 5 - Stock Options link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 6 - COVID-19 link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. (Tables) link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 2 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. (Details Textual) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 4 - Common Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 5 - Stock Options (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 ovtz-20200930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 ovtz-20200930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 ovtz-20200930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Non-Cash Financing and Investing Activities us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) Note To Financial Statement Details Textual Increase (decrease) in accounts payable and accrued expenses us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Intangible asset Common Stock Including Additional Paid in Capital [Member] Note 3 - Acquisition of OCL Technologies Corp. Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions Notes To Financial Statements Notes To Financial Statements [Abstract] Equity Components [Axis] Equity Component [Domain] Cash us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Add back non-cash share-based compensation us-gaap_LiabilitiesCurrent Total current liabilities Accounts payable and accrued expenses - related parties us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year) Common stock issued on acquisition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Total Purchase Price us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding (in shares) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired Increase (decrease) in accounts payable and accrued expenses due to related parties us-gaap_IncreaseDecreaseInDueToRelatedParties Cash and cash equivalents us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap_SharesIssued Balance (in shares) Balance (in shares) us-gaap_SharesIssuedPricePerShare Shares Issued, Price Per Share (in CAD per share) us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) us-gaap_AssetsCurrent Total current assets Stockholders' Equity Note Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) Amendment Flag Accounting Policies [Abstract] Warrants issued on acquisition (in shares) Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 86,522,569 Entity Interactive Data Current Account payable acquired on acquisition Common stock, shares authorized (in shares) Common stock, shares outstanding (in shares) Accounts payable and accrued expenses Common stock, shares issued (in shares) Title of 12(b) Security us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Intangible acquired on acquisition Common stock, no par value (in dollars per share) Current Fiscal Year End Date us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Decrease (increase) in prepaid expenses and other current assets Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Entity Ex Transition Period Entity Emerging Growth Company Document Type Preferred stock - no par value; authorized 250,000,000 shares, none issued Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Entity Small Business Preferred stock, shares issued (in shares) Entity Shell Company Cash paid during the period for interest us-gaap_PolicyTextBlockAbstract Accounting Policies Cash paid during the period for income taxes Preferred stock, par value (in dollars per share) Document Information [Line Items] Document Information [Table] Preferred stock, authorized (in shares) Entity Filer Category Unusual or Infrequent Item, or Both [Axis] Entity Current Reporting Status Unusual or Infrequent Item, or Both [Domain] Revenue Unusual or Infrequent Items, or Both, Disclosure [Text Block] Weighted average number of common shares outstanding – basic and diluted (in shares) Contingent consideration us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Share-based compensation us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Net loss per share - basic and diluted (in dollars per share) Entity Central Index Key Entity Registrant Name Current Liabilities: Entity [Domain] Vesting [Axis] Legal Entity [Axis] Vesting [Domain] Statement [Table] Share-based Payment Arrangement, Tranche One [Member] Statement of Financial Position [Abstract] Issuance cost Supplemental disclosures of cash flow information: us-gaap_Assets Total Assets Plan Name [Axis] Interest income (expense) Plan Name [Domain] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Cash flows from operating activities: COVID-19 [Member] Represents COVID-19. ovtz_WorkingCapitalDeficit Working Capital (Deficit) Represents the amount of difference between Current Assets and Current Liabilities. Statement of Cash Flows [Abstract] Commitment to issue shares (Note 3) Warrants and Rights Outstanding Statement [Line Items] Entity Common Stock, Shares Outstanding (in shares) Mergers, Acquisitions and Dispositions Disclosures [Text Block] Statement of Stockholders' Equity [Abstract] Income Statement [Abstract] Commitment to Issue Shares [Member] Represents commitment to issue shares. Share-based Payment Arrangement [Text Block] Transaction costs Stockholders' Equity: Trading Symbol us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Award Type [Domain] Shares issued for asset acquisition (Note 3) (in shares) Net loss us-gaap_NetIncomeLoss Net loss Net loss Award Type [Axis] Shares issued for asset acquisition (Note 3) us-gaap_TableTextBlock Notes Tables us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Intangible assets (Note 3) ASSETS us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net increase in cash and cash equivalents us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash from financing activities Warrants Issued in Connection With Business Acquisition [Member] Represents warrants issued in connection with business acquisition. Commitments and Contingencies OCL Technologies Corp [Member] Represents OCL Technologies Corp. us-gaap_OperatingIncomeLoss Loss from operations Share-based Payment Arrangement, Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Other income (expense) us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash from investing activities us-gaap_PrepaidExpenseAndOtherAssetsCurrent Prepaid expenses and other current assets Selling, general and administrative Counterparty Name [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) Cash flows from financing activities Counterparty Name [Domain] us-gaap_WarrantsAndRightsOutstandingTerm Warrants and Rights Outstanding, Term (Year) us-gaap_StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues (in shares) Schedule of Business Acquisitions, by Acquisition [Table Text Block] us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Equity Sale of common stock Sale of common stock Shares issued (in shares) Amount of equity interests of the acquirer in shares, including instruments or interests issued or issuable in consideration for the business combination. Accumulated deficit Retained Earnings (Accumulated Deficit), Ending Balance Research and development us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Total Purchase Price Investors [Member] Represents the investors of the company. Employee and Directors [Member] Represents the employee and directors of the company. Changes in operating assets and liabilities: us-gaap_StockholdersEquity Stockholders' equity Balance Balance ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved The percent of issued and outstanding common shares reserved in a share-based compensation. us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] us-gaap_CostsAndExpenses Total expenses Class of Stock [Axis] Rolling Stock Option Plan [Member] Related to the Rolling Stock Option Plan. Cash acquired on asset acquisition Cash flows from investing activities Expenses: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Accounts payable and due from related party Retained Earnings [Member] ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Represents the fair value of options under the share-based compensation. Title of Individual [Domain] Proceeds from the sale of common stock Title of Individual [Axis] EX-101.PRE 11 ovtz-20200930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2020
Nov. 09, 2020
Document Information [Line Items]    
Entity Registrant Name OCULUS VISIONTECH INC.  
Entity Central Index Key 0001107280  
Trading Symbol ovtz  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Small Business true  
Entity Interactive Data Current Yes  
Entity Common Stock, Shares Outstanding (in shares)   86,522,569
Entity Shell Company false  
Document Type 10-Q  
Document Period End Date Sep. 30, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Title of 12(b) Security Common Stock  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
ASSETS    
Cash and cash equivalents $ 695,835 $ 382,452
Prepaid expenses and other current assets 4,686 1,267
Total current assets 700,521 383,719
Intangible assets (Note 3) 1,966,939
Total Assets 2,667,460 383,719
Current Liabilities:    
Accounts payable and accrued expenses 50,611 5,431
Accounts payable and accrued expenses - related parties 135,484 129,985
Total current liabilities 186,095 135,416
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock - no par value; authorized 250,000,000 shares, none issued 0 0
Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 86,522,569 43,908,562 41,634,999
Commitment to issue shares (Note 3) 414,128
Accumulated deficit (41,841,325) (41,386,696)
Stockholders' equity 2,481,365 248,303
Total Liabilities and Stockholders' Equity $ 2,667,460 $ 383,719
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
$ / shares in Thousands
Sep. 30, 2020
Dec. 31, 2019
Preferred stock, par value (in dollars per share) $ 0 $ 0
Preferred stock, authorized (in shares) 250,000,000 250,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, no par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 86,522,569 86,522,569
Common stock, shares outstanding (in shares) 86,522,569 86,522,569
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenue
Expenses:        
Research and development 93,270 130,180
Selling, general and administrative 83,605 43,098 204,447 165,264
Share-based Payment Arrangement, Expense 120,098 120,098
Total expenses 296,973 43,098 454,725 165,264
Loss from operations (296,973) (43,098) (454,725) (165,264)
Other income (expense)        
Interest income (expense) 281 96 281
Net loss $ (296,973) $ (42,817) $ (454,629) $ (164,983)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0 $ (0.01) $ 0
Weighted average number of common shares outstanding – basic and diluted (in shares) 86,522,569 67,022,568 78,165,426 53,665,425
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock Including Additional Paid in Capital [Member]
Commitment to Issue Shares [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2018 45,572,568      
Balance at Dec. 31, 2018 $ 40,458,297 $ (41,193,831) $ (735,534)
Stock Issued During Period, Shares, New Issues (in shares) 21,450,000      
Sale of common stock $ 1,176,702 1,176,702
Sale of common stock 1,176,702 1,176,702
Net loss (164,983) (164,983)
Balance (in shares) at Sep. 30, 2019 67,022,568      
Balance at Sep. 30, 2019 $ 41,634,999 (41,358,814) 276,185
Balance (in shares) at Dec. 31, 2018 45,572,568      
Balance at Dec. 31, 2018 $ 40,458,297 (41,193,831) (735,534)
Net loss       (192,865)
Balance (in shares) at Dec. 31, 2019 67,022,568      
Balance at Dec. 31, 2019 $ 41,634,999 (41,386,696) 248,303
Stock Issued During Period, Shares, New Issues (in shares) 7,000,001      
Sale of common stock $ 773,038 773,038
Sale of common stock 773,038 773,038
Net loss (454,629) (454,629)
Shares issued for asset acquisition (Note 3) (in shares) 12,500,000      
Shares issued for asset acquisition (Note 3) $ 1,380,427 1,380,427
Contingent consideration 414,128 414,128
Share-based compensation $ 120,098 120,098
Balance (in shares) at Sep. 30, 2020 86,522,569      
Balance at Sep. 30, 2020 $ 43,908,562 $ 414,128 $ (41,841,325) $ 2,481,365
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals)
9 Months Ended
Sep. 30, 2019
USD ($)
Issuance cost $ 32,416
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:            
Net loss $ (296,973) $ (42,817) $ (454,629) $ (164,983) $ (192,865) $ (183,279)
Add back non-cash share-based compensation     120,098    
Changes in operating assets and liabilities:            
Decrease (increase) in prepaid expenses and other current assets     (3,419) 461    
Increase (decrease) in accounts payable and accrued expenses     (241,373) (48,706)    
Increase (decrease) in accounts payable and accrued expenses due to related parties     5,499 (556,154)    
Net cash used in operating activities     (573,824) (769,382)    
Cash flows from investing activities            
Cash acquired on asset acquisition     114,169    
Net cash from investing activities     114,169    
Cash flows from financing activities            
Proceeds from the sale of common stock     773,038 1,176,702    
Net cash from financing activities     773,038 1,176,702    
Net increase in cash and cash equivalents     313,383 407,320    
Cash and cash equivalents at beginning of period     382,452 5,572 5,572  
Cash and cash equivalents at end of period $ 695,835 $ 412,892 695,835 412,892 $ 382,452 $ 5,572
Supplemental disclosures of cash flow information:            
Cash paid during the period for interest        
Cash paid during the period for income taxes        
Non-Cash Financing and Investing Activities            
Common stock issued on acquisition     1,380,427    
Intangible acquired on acquisition     $ (1,966,939)    
Warrants issued on acquisition (in shares)     414,128    
Account payable acquired on acquisition     $ 172,384    
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Note 1 - Basis of Presentation
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
1.
BASIS OF PRESENTATION
  
These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended
December 31, 2019.
These unaudited condensed interim consolidated financial statements do
not
include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended
December 31, 2019,
except when disclosed below.
  
The accompanying consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, USVO Inc. (dissolved
December 31, 2019)
and OCL Technologies Corp. (from the date of acquisition, Note
3
). All intercompany balances and transactions have been eliminated upon consolidation.   In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are
not
necessarily indicative of the results that
may
be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company's annual report on Form
10
-K for the fiscal year ended
December 31, 2019.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Note 2 - Going Concern
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
2.
GOING CONCERN
  
The accompanying unaudited condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As shown in the financial statements, the Company has incurred a loss of
$454,629
for the
nine
month period ended
September 30, 2020
and, in addition the Company incurred losses of
$192,865
and
$183,279
for the years ended
December 31, 2019
and
2018,
respectively. As of
September 30, 2020,
the Company had an accumulated deficit of
$41,841,325
and a working capital of
$514,426.
These conditions raise doubt about the Company's ability to continue as a going concern.  The Company's ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company's management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company's management will continue to be available to the Company when needed.  The financial statements do
not
include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Note 3 - Acquisition of OCL Technologies Corp.
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Mergers, Acquisitions and Dispositions Disclosures [Text Block]
3.
ACQUISITION OF OCL TECHNOLOGIES CORP. 
 
During the period ended
September 30, 2020,
the Company acquired a
100%
interest in OCL Technologies Corp. (“OCL”) by issuing
12,500,000
shares with a fair value of
$1,380,427
and contingent consideration consisting of
12,500,000
non transferable warrants with a fair value of
$414,128.
The transaction does
not
meet the definition of a business as defined in ASC
805
-
10.
As a result, the acquisition of OCL has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, OCL became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:
 

 
Purchase Price
       
         
Issuance of 12,500,000 shares
  $
1,380,427
 
Contingent consideration - warrants
   
414,128
 
Transaction costs
   
54,532
 
         
Total Purchase Price
  $
1,849,087
 
 
Contingent consideration consists of
12,500,000
non-transferable warrants that are exercisable into
12,500,000
common shares if certain criteria are met at an exercise price of
$0.001
for a period of
five
years from the date of issuance expiry
June 4, 2025.
No
share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being
1
) revenue sales projections per OCL's
5
year proformas, or
2
) listing on a major US exchange, or
3
) change of control. The Company has estimated the fair value of the contingent consideration to be
$414,128.
 

 
Purchase Price Allocation
       
         
Cash
  $
114,169
 
Accounts payable and due from related party
   
(232,021
)
Intangible asset
   
1,966,939
 
         
Total Purchase Price
  $
1,849,087
 
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Note 4 - Common Stock
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
4
.
COMMON STOCK 
 
On
June 19, 2019,
the Company issued
7,500,000
shares to a consultant and directors at
$0.075
CND per share.
 
On
June 19, 2019,
the Company issued
13,950,000
shares to investors at
$0.075
CND per share.
 
On
June 5, 2020,
the Company issued
12,500,000
shares at a value of
$0.15
CND per share pursuant to the acquisition of OCL Technologies Corp.
 
On
June 5, 2020,
the Company issued
7,000,001
shares to investors, including
1,766,667
common shares to a consultant and directors at
$0.15
CND per share.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Note 5 - Stock Options
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
5
.
STOCK OPTIONS  
 
On
September 30, 2019,
the Company adopted Rolling Stock Option Plan. Up to
10%
of the Company's issued and outstanding common shares
may
be reserved for granting of stock options.
 
During the period ended
September 30, 2020,
the Company granted
3,600,000
stock options to consultants, directors and officers exercisable into
3,600,000
shares at an exercise price of
$0.35CND
and an expiry date of
July 21, 2023.
The options have a fair value of
$909,900CND,
calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of
125%;
(ii) Term of
3
years; (iii) Discount rate of
0.27%;
(iv) Dividend rate of
Nil;
and (v) market stock price of
$0.35.
The options vest
20%
every
6
months starting
January 21, 2020.
During the period ended
September 30, 2020,
the Company recorded
$160,990CND
(
$120,098US
) of stock-based compensation relating to the vesting period.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Note 6 - COVID-19
9 Months Ended
Sep. 30, 2020
COVID-19 [Member]  
Notes to Financial Statements  
Unusual or Infrequent Items, or Both, Disclosure [Text Block]
6
.
COVID-
19
  
 
In early
2020,
a coronavirus that causes COVID-
19
emerged globally, which is currently affecting the global economies and has a resulting effect on the Company. Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.
  
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Note 3 - Acquisition of OCL Technologies Corp. (Tables)
9 Months Ended
Sep. 30, 2020
Notes Tables  
Schedule of Business Acquisitions, by Acquisition [Table Text Block]
Purchase Price
       
         
Issuance of 12,500,000 shares
  $
1,380,427
 
Contingent consideration - warrants
   
414,128
 
Transaction costs
   
54,532
 
         
Total Purchase Price
  $
1,849,087
 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Purchase Price Allocation
       
         
Cash
  $
114,169
 
Accounts payable and due from related party
   
(232,021
)
Intangible asset
   
1,966,939
 
         
Total Purchase Price
  $
1,849,087
 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Note 2 - Going Concern (Details Textual) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Net loss $ (296,973) $ (42,817) $ (454,629) $ (164,983) $ (192,865) $ (183,279)
Retained Earnings (Accumulated Deficit), Ending Balance (41,841,325)   (41,841,325)   $ (41,386,696)  
Working Capital (Deficit) $ (514,426)   $ (514,426)      
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Note 3 - Acquisition of OCL Technologies Corp. (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 1,380,427  
Warrants and Rights Outstanding $ 414,128  
OCL Technologies Corp [Member]      
Business Acquisition, Percentage of Voting Interests Acquired 100.00%    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) 12,500,000    
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 1,380,427    
Warrants and Rights Outstanding 414,128    
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]      
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 414,128    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) 12,500,000    
Warrants and Rights Outstanding $ 414,128    
Class of Warrant or Right, Outstanding (in shares) 12,500,000    
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) $ 0.001    
Warrants and Rights Outstanding, Term (Year) 5 years    
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Common stock issued on acquisition $ 1,380,427
OCL Technologies Corp [Member]    
Common stock issued on acquisition 1,380,427  
Transaction costs 54,532  
Total Purchase Price 1,849,087  
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]    
Common stock issued on acquisition $ 414,128  
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals)
9 Months Ended
Sep. 30, 2020
shares
OCL Technologies Corp [Member]  
Shares issued (in shares) 12,500,000
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) - OCL Technologies Corp [Member]
Sep. 30, 2020
USD ($)
Cash $ 114,169
Accounts payable and due from related party (232,021)
Intangible asset 1,966,939
Total Purchase Price $ 1,849,087
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Note 4 - Common Stock (Details Textual) - $ / shares
Jun. 05, 2020
Jun. 19, 2019
Employee and Directors [Member]    
Stock Issued During Period, Shares, New Issues (in shares) 1,766,667 7,500,000
Shares Issued, Price Per Share (in CAD per share) $ 0.15 $ 0.075
Investors [Member]    
Stock Issued During Period, Shares, New Issues (in shares) 7,000,001 13,950,000
Shares Issued, Price Per Share (in CAD per share) $ 0.15 $ 0.075
OCL Technologies Corp [Member]    
Stock Issued During Period, Shares, New Issues (in shares) 12,500,000  
Shares Issued, Price Per Share (in CAD per share) $ 0.15  
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Note 5 - Stock Options (Details Textual)
3 Months Ended 9 Months Ended
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
shares
Sep. 30, 2020
CAD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
Share-based Payment Arrangement, Expense | $ $ 120,098 $ 120,098  
Rolling Stock Option Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares     3,600,000 3,600,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) | shares       3,600,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares       $ 0.35  
Rolling Stock Option Plan [Member]          
Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved   10.00%     10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $       $ 909,900  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares       $ 0.35  
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     125.00% 125.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)     3 years 3 years  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions     0.27% 0.27%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate     0.00% 0.00%  
Share-based Payment Arrangement, Expense     $ 120,098 $ 160,990  
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | Share-based Payment Arrangement, Tranche One [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     20.00% 20.00%  
EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 51 189 1 false 13 0 false 6 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oculusvisiontech.com/20200930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.oculusvisiontech.com/20200930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.oculusvisiontech.com/20200930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.oculusvisiontech.com/20200930/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.oculusvisiontech.com/20200930/role/statement-consolidated-statements-of-stockholders-equity-unaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Sheet http://www.oculusvisiontech.com/20200930/role/statement-consolidated-statements-of-stockholders-equity-unaudited-parentheticals Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.oculusvisiontech.com/20200930/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Basis of Presentation Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-1-basis-of-presentation Note 1 - Basis of Presentation Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Going Concern Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-2-going-concern Note 2 - Going Concern Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp Note 3 - Acquisition of OCL Technologies Corp. Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Common Stock Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-4-common-stock Note 4 - Common Stock Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Stock Options Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-5-stock-options Note 5 - Stock Options Notes 12 false false R13.htm 012 - Disclosure - Note 6 - COVID-19 Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-6-covid19 Note 6 - COVID-19 Notes 13 false false R14.htm 013 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. (Tables) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp-tables Note 3 - Acquisition of OCL Technologies Corp. (Tables) Tables http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp 14 false false R15.htm 014 - Disclosure - Note 2 - Going Concern (Details Textual) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-2-going-concern-details-textual Note 2 - Going Concern (Details Textual) Details http://www.oculusvisiontech.com/20200930/role/statement-note-2-going-concern 15 false false R16.htm 015 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. (Details Textual) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp-details-textual Note 3 - Acquisition of OCL Technologies Corp. (Details Textual) Details http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp-tables 16 false false R17.htm 016 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp-purchase-price-details Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) Details 17 false false R18.htm 017 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp-purchase-price-details-parentheticals Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) Details 18 false false R19.htm 018 - Disclosure - Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-3-acquisition-of-ocl-technologies-corp-purchase-price-allocation-details Note 3 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) Details 19 false false R20.htm 019 - Disclosure - Note 4 - Common Stock (Details Textual) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-4-common-stock-details-textual Note 4 - Common Stock (Details Textual) Details http://www.oculusvisiontech.com/20200930/role/statement-note-4-common-stock 20 false false R21.htm 020 - Disclosure - Note 5 - Stock Options (Details Textual) Sheet http://www.oculusvisiontech.com/20200930/role/statement-note-5-stock-options-details-textual Note 5 - Stock Options (Details Textual) Details http://www.oculusvisiontech.com/20200930/role/statement-note-5-stock-options 21 false false All Reports Book All Reports ovtz-20200930.xml ovtz-20200930.xsd ovtz-20200930_cal.xml ovtz-20200930_def.xml ovtz-20200930_lab.xml ovtz-20200930_pre.xml http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 38 0001437749-20-023178-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-20-023178-xbrl.zip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end